# PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension

> **NCT02058446** · PHASE4 · COMPLETED · sponsor: **TSH Biopharm Corporation Limited** · enrollment: 36 (actual)

## Conditions studied

- Essential Hypertension

## Interventions

- **DRUG:** Amlodipine/Valsartan

## Key facts

- **NCT ID:** NCT02058446
- **Lead sponsor:** TSH Biopharm Corporation Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2015-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02058446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02058446, "PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02058446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*